Diversified Financial Services
Company Overview of Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc.
In July 2000, Curis, Inc. completed a merger with Creative BioMolecules, Inc.; Ontogeny, Inc.; and Reprogenesis, Inc., pursuant to which Curis was owned approximately 43% by the former stockholders of Creative, approximately 38% by the former stockholders of Ontogeny, and approximately 19% by the former stockholders of Reprogenesis. Previously, Curis, Inc. did not have any significant operations and was formed to effect a merger.
61 Moulton Street
Cambridge, MA 02138
Founded in 2000
Key Executives for Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc.
Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|1199 S.E.I.U. Federal Credit Union||United States|
|121 Financial Credit Union||United States|
|123 LumpSum Holdings, LLC||United States|
|12five Capital, LLC||United States|
|167th TFR Federal Credit Union||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.